Unilateral recurrent central serous chorioretinopathy (CSCR) following COVID-19 vaccination- A multimodal imaging study
Corona virus disease-19 (COVID-19) vaccines have been approved for emergency use. Ocular adverse effects following the vaccines have been reported. Purpose: To report an unique case of recurrent central serous chorioretinopathy following both doses of COVID-19 vaccine. Observations: A 40-year-old ma...
Main Authors: | Srinivasan Sanjay, Isha Acharya, Ankush Kawali, Rohit Shetty, Padmamalini Mahendradas |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | American Journal of Ophthalmology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451993622003905 |
Similar Items
-
Oral eplerenone for the management of chronic central serous chorioretinopathy
by: Rishi P Singh, et al.
Published: (2015-04-01) -
Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study
by: Hamid-Reza Moein, et al.
Published: (2019-09-01) -
Management of chronic central serous chorioretinopathy
by: Daren Hanumunthadu, et al.
Published: (2018-01-01) -
Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone – a case report
by: Ramesh Venkatesh, et al.
Published: (2020-06-01) -
Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone
by: William J. Anderson, et al.
Published: (2022-12-01)